Iron Deficiency in Heart Failure Patients

Overview

Heart failure is a common problem with a prevalence of 1-2% in general population and a major cause of mortality,morbidity and impaired quality of life. Anemia is afrequent comorbidity in stable heart failure patients and it increases morbidity in terms of frequent hospital admissions,impaired exercise capacity,poor quality of life ,and increased mortality

Full Title of Study: “Percentage and Spectrum of Iron Deficiency in Systolic Heart Failure Patients in Assiut University Hospital”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: March 26, 2020

Detailed Description

Iron deficiency with or without anemia has been commonly associated with heart failure .Although iron deficiency is the commonest nutritional deficiency worldwide ,affecting more than one-third of the population,its association with heart failure with or without anemia is of growing interest .As iron supplementation improves prognosis in patients with heart failure ,iron deficiency is an attractive therapeutic target. In 2012 ,the European society of cardiology Guidelines for the diagnosis and treatment of acute and chronic heart failure recognized iron deficiency as a comorbidity in heart failure for the first time and recommended diagnosis of iron deficiency based on iron parameters in all patients suspected of having heart failure. Iron deficiency can be classified as absolute or functional. Absolute iron deficiency reflects depleted body stores caused by poor dietary intake, impaired gastrointestinal absorption,and chronic blood loss. Functional iron deficiency is thought to be caused by increased hepcidin production and subsequent inhibition of the iron exporter ferroportin ,leading to impaired absorption and utilization of iron. Chronic heart failure patients are susceptible to both forms iron deficiency Aetiology of iron deficiency in chronic heart failure: The aetiology is multifactorial and complex 1. reduced dietary intake 2. chronic blood loss 3. chronic heart failure causes an inflammatory state which leads to increased hepcidin levels and subsequent iron deficiency due to reduced iron absorption and enhanced reticuloendothelial block

Arms, Groups and Cohorts

  • 1 group
    • Complete iron profile serum iron serum ferritin total iron binding capacity transferrin saturation (TSAT)

Clinical Trial Outcome Measures

Primary Measures

  • percentage of iron deficiency in systolic heart failure patients
    • Time Frame: 1 year
    • systolic heart failure is defined as ejection fraction <50% absolute iron deficiency is serum ferritin<100ug/l.Functional iron deficiency is defined as normal serum ferritin(100-300)ug/l with low transferrin saturation<20%

Participating in This Clinical Trial

Inclusion Criteria

.100 males or females patients above age of 18years of age and clinically diagnosed with systolic heart failure,ejection fraction<50% by echocardiography admitted in Assiut University hospital Exclusion Criteria:

.Known to be non cardiac condition causing iron deficiency(haemorrhoids,malignancy). .other conditions causing fluid overload(eg.renal failure on dialysis ). .congenital heart disease.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Assiut University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Essam Nan Saleeb, Principal Investigator – Assiut University
  • Overall Contact(s)
    • Amr Youssef, MD, 0100655404, amryousef111@yahoo.com

Citations Reporting on Results

Cleland JG, Khand A, Clark A. The heart failure epidemic: exactly how big is it? Eur Heart J. 2001 Apr;22(8):623-6. doi: 10.1053/euhj.2000.2493. No abstract available.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.